Scout | Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

This opportunity is no longer accepting applications.

grant

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

This grant aims to support research focused on discovering and developing new small molecules that could help study treatments for psychiatric disorders. Additionally, it seeks to enhance understanding of the biology of diseases and processes that are still being explored as potential drug targets.

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Mental Health

Program: SBIR

Dates

Open for Submission: April 17, 2023

Application Window Closes: May 7, 2026

Opportunity Released: April 17, 2023

Submission Deadline: May 7, 2026

Keywords

novel small molecules

psychiatric disorders

disease treatment

drug target discovery

biological research

psychiatric disease biology

therapeutic development

psychiatric research funding

disease process insight

molecular drug development

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers